Latest Organofluorides Stories
PHILADELPHIA, March 20, 2015 /PRNewswire/ -- A Philadelphia jury today affirmed by a 10-2 vote that Janssen Pharmaceuticals, a division of Johnson & Johnson, failed to warn of the risk to
WASHINGTON, March 18, 2015 /PRNewswire/ -- USPLabs Inc. has been made aware that U.S.
--- Significant Survival Benefit Observed in Pre-Specified Subgroups Including Patients with Brain Metastases and Patients with Baseline Liver Metastases --- SAN FRANCISCO, March
DALLAS, March 17, 2015 /PRNewswire/ -- The report "Fluorosurfactants Market by Type (Amphoteric, Nonioninc, Anionic and Cationic), by Application (Paints & Coatings,
The Firm is looking forward to a status conference on March 19, 2015 that will discuss issues that affect hundreds of Risperdal lawsuit claimants. New York,
DUBLIN, March 9, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that it has launched a generic version of Fougera's Temovate(®)
The Firm is representing numerous plaintiffs who have filed Risperdal lawsuits in Pennsylvania that allege the antipsychotic medication caused gynecomastia, or male breast development.
The Firm is representing numerous clients in Risperdal lawsuits that have been filed in the Pennsylvania mass tort proceeding, all of whom allegedly developed gynecomastia due to treatment with
NORWALK, Conn., March 5, 2015 /PRNewswire/ -- UBM Medica US announces that OncoTherapy Network,
BAUDETTE, Minn., March 5, 2015 /PRNewswire/ -- ANI Pharmaceuticals, Inc.